Zealand Pharma enters $1.25bn obesity AI collaboration
Danish biotechnology company Zealand Pharma has announced a multi-target strategic collaboration with US-based Generate Biomedicines to design and develop novel protein therapeutics for obesity and other metabolic diseases. Under the terms of the agreement, Generate will receive an upfront payment of $30m and up to $35m in early preclinical milestones for the first two programmes. Generate is also eligible to…